Monetary Valuation

Natural Capital Accounting in Marine Protected Areas: The Case of the Islands of Ventotene and S. Stefano (Central Italy)

23rd August 2017
Published under: Case Studies,Data Tools & Methodologies

This paper was originally published in Ecological Modeling.  Highlights:  A biophysical and trophodynamic model based on emergy accounting was applied. The interactions between different benthic habitat was explored. The ecological value of natural capital stocks was calculated. A GIS tool was used to show the spatial distribution of natural capital in the MPA. The applied… [more]

The Future Value of Ecosystem Services: Global Scenarios & National Implications

18th August 2017
Published under: Data Tools & Methodologies

This paper was originally published on idakub.com. “Abstract: We estimated the future value of ecosystem services in monetary units for 4 alternative global land use and management scenarios based on the Great Transition Initiative (GTI) scenarios to the year 2050. We used previous estimates of the per biome values of ecosystem services in 2011 as the… [more]

Integrating Natural Capital Assessment & Marine Spatial Planning: A Case Study in the Mediterranean Sea

6th August 2017
Published under: Case Studies,Data Tools & Methodologies

This paper was originally published on ScienceDirect.  Highlights Natural capital value was assessed in the Egadi islands MPA through emergy accounting. The value of both autotrophic and heterotrophic natural capital stocks was calculated. Marxan software was used to identify key areas for natural capital conservation. Environmental accounting outcomes were integrated with spatial data on human… [more]

Natural Capital Protocol: Case Study for Novartis

22nd June 2017
Published under: Case Studies,Featured

The company in brief: Novartis is a multinational pharmaceutical company based in Switzerland, and one of the largest pharmaceutical companies by both market cap and sales. Novartis develops, manufactures, and markets healthcare products, providing solutions for patients worldwide. The company operates in the segments of innovative pharmaceuticals, eyecare, generics, vaccines/diagnostics and consumer health. Why a… [more]